Clinical Trial Update: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing [NA]

View source ↗

Summary

This clinical trial update notes the ongoing evaluation of the EMPOWER Modular Pacing System and EMBLEM Subcutaneous ICD for communicating antitachycardia pacin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Ventricular Tachycardia

Drugs mentioned

• EMBLEM Subcutaneous ICD
• EMPOWER Modular Pacing System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Tachycardia, Ventricular, Arrhythmia, Ventricular | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-26